Lisa D. Earnhardt, President and CEO at Intersect ENT, Inc. (XENT), sold 15,000 shares at $39.59 ($594K) on 2018-04-16, disclosed to the SEC on 2018-04-17.
Seasonal sale ($594k) by President and CEO — this insider has traded XENT in April in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| ABT | SELL | 2024-03-04 | $82K | — | Filing → |
| ABT | SELL | 2023-03-02 | $190K | — | Filing → |
| ABT | SELL | 2022-03-02 | $223K | — | Filing → |